RNARCHITECTURE
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Jun 2017)
What this means for you
This application is over — abandoned 19 Jun 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86374590
- Mark type
- Stylized text
- Filed
- 22 Aug 2014
- Published for opposition
- 22 Mar 2016
- Abandoned
- 19 Jun 2017
- Attorney of record
- David A. Jackson
Goods and services
- Class 001 — Chemicals: CHEMICAL REAGENTS AND BIOMOLECULES, IN PARTICULAR BIOLOGICAL MACROMOLECULES FOR INDUSTRY AND SCIENCE, REAGENTS FOR RESEARCH PURPOSES, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
- Class 005 — Pharmaceuticals: CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERNARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
- Class 044 — Medical, beauty and agricultural services: MEDICAL AND VETERINARY SERVICES, IN PARTICULAR FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT OF TUMOR DISEASES, INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND ALLERGIES, FOR THE TREATMENT OF HEREDITARY DISORDERS AND FOR PROTEIN OR ENZYME SUPPLEMENT THERAPY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISORDERS AND FOR THE TREATMENT OF ENDOCRINOLOGICAL DISORDERS
Owner
- CUREVAC AG, TUEBINGEN, DE
- CureVac GmbH, Tubingen, DE
- CureVac GmbH, Tubingen, DE
Prosecution history
- 19 Jun 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 19 Jun 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Nov 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Oct 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2016 — SOU EXTENSION 1 GRANTED
- 30 Sept 2016 — SOU EXTENSION 1 FILED
- 30 Sept 2016 — SOU TEAS EXTENSION RECEIVED
- 17 May 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Mar 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Mar 2016 — PUBLISHED FOR OPPOSITION
- 02 Mar 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Feb 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 Feb 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Feb 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE